Modulation of antitumor T cell responses induced by everolimus in metastatic Renal Cell Carcinoma patients

Authors :: Laurent Beziaud
Bernard Royer
Guillaume Mouillet
Thierry Nguyen
Laura Mansi
Caroline Laheurte
Olivier Adotevi
Tristan Maurina
Claire Jacquemard
Christophe Borg
Lise Queiroz
Yann Godet
Antoine Thiery-Vuillemin
Source :: Journal of Clinical Oncology. 33:e22113-e22113
Publication Year :: 2015
Publisher :: American Society of Clinical Oncology (ASCO), 2015.
Abstract: e22113 Background: Everolimus has demonstrated activity in the treatment of metastastic renal cell carcinoma (mRCC) after failure of VEGF-targeted tyrosine kinase inhibitor. However, accumulating e...

Subjects :: Cancer Research
Everolimus
medicine.drug_class
business.industry
T cell
Pharmacology
urologic and male genital diseases
medicine.disease
Tyrosine-kinase inhibitor
medicine.anatomical_structure
Oncology
Renal cell carcinoma
medicine
business
medicine.drug

Tools